MEDICEPTION is offering 3 months Training course on Medical Writing from our experts. Pharma & Biotech fresher's may send their query for...

MEDICEPTION Set-up a Booth at OPPI Medical Forum meeting at Mumbai, 3rd May. It was great meeting to dignitaries from Pharma, Government...

MEDICEPTION announces to be a proud SPONSOR of OPPI (Organisation of Pharmaceutical Producers of India) 2018 to be held on 3rd May,...

MDR_TB is becoming a threat in India. With only 50% treatment survival rate and Un-affordable therapy cost, would lead to an increase in...

Engaged in Ph IV #Observational_study (#RWE Study) of an Oncology drug in patients unsuitable to Pt Therapy.

MEDICEPTION partnering with SAYRE therapeutics for data analysis from their first retrospective clinical study of an oncology drug

We are collaborating with ALKEM LABS for Oncology clinical trial data analysis and its publication. This would be a continuous ongoing ...

MEDICEPTION collaborating for a Ph IV drug for its Efficacy and safety evaluations in Indian Patients..!!

Collaborating with RnR Clinicians for Patient data analysis

MEDICEPTION recently collaborated with a Chinese company for carrying out their complete Ph III vaccine trial in India. The collaboration...